Physician profile
David P Rhoads
NPI 1992852909
$2,007.44
in general payments reported to CMS, 2019-2025
17 companies · $539 in 2025
The $539 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $144 · 2021: $593 · 2022: $280 · 2023: $149 · 2024: $181 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $580 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $579.65 |
| Food and Beverage | $289.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,341.74 | 2019-2025 | Persona, Identity, Comprehensive Shoulder System |
| Pacira Therapeutics, INC. | $145.91 | 2019-2021 | |
| Pfizer INC. | $88.59 | 2019-2022 | |
| Depuy Synthes Sales INC. | $84.03 | 2021-2025 | Vapr, Fms, Fms Duo |
| Smith+Nephew, INC. | $65.92 | 2022-2024 | Trigen Intertan |
| Paratek Pharmaceuticals, INC. | $58.91 | 2022-2023 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $35.52 | 2025 | |
| Heron Therapeutics, INC. | $28.74 | 2021 | |
| Horizon Therapeutics Plc | $24.62 | 2020-2021 | |
| Radius Health, INC. | $22.25 | 2020 | |
| Amgen INC. | $21.56 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.48 | 2020 | |
| Bioventus LLC | $16.25 | 2022 | |
| Vericel Corporation | $15.78 | 2023 | Maci |
| Pacira Pharmaceuticals Incorporated | $14.06 | 2023 | Exparel, Zilretta, Iovera |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.96 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rhoads listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.